Clinical Trial Update: Adjusted Fibrinogen Replacement Strategy [Phase 3]

View source ↗

Summary

Phase 3 study evaluating an adjusted fibrinogen replacement strategy in acquired hypofibrinogenemia with bleeding disorders has completed and results were poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bleeding Disorders
• Hypofibrinogenemia Acquired

Snippet

Sponsor: Biotest | Conditions: Bleeding Disorder, Hypofibrinogenemia; Acquired | Phase 3 | Status: COMPLETED | Results posted: 2025-06-13